The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,266.00
Bid: 4,261.00
Ask: 4,262.00
Change: 37.00 (0.87%)
Spread: 1.00 (0.023%)
Open: 4,231.00
High: 4,266.00
Low: 4,228.00
Prev. Close: 4,229.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Director Remuneration Report AGM Vote

30 Oct 2023 16:33

RNS Number : 7569R
Unilever PLC
30 October 2023
 

Unilever PLC

Statement detailing outcome of shareholder engagement following Directors' Remuneration Report (DRR) vote at the Annual General Meeting (AGM) on 3 May 2023

 

At the 2023 AGM, the resolution to receive and adopt the Directors' Remuneration Report (Resolution 2) was not passed, with a minority of 42% of votes cast in favour of the resolution. 

 

Following the AGM, the Company has undertaken an extensive engagement exercise with shareholders to discuss this voting outcome. During this period, we contacted 28 of our largest shareholders representing around 40% of the shares on our shareholder register, inviting them to meet. 24 shareholders accepted this invitation and we conducted a total of 37 meetings during the engagement exercise.

 

The feedback received from this process informed us that the primary reason for the limited support for the DRR was the approach taken to setting the incoming CEO's remuneration on appointment. Specifically, whilst the majority of shareholders agreed that the fixed pay level for the new CEO appropriately reflected the size and complexity of the role, there was a preference that alignment with the market could have been achieved gradually, rather than in one step on appointment.

 

The Compensation Committee considered this feedback carefully and the Board has decided to freeze the CEO's fixed pay for the next two years. Therefore, he will not be eligible for a fixed pay increase in 2024 or 2025, with the Compensation Committee next reviewing his fixed pay level in 2026. This approach of restricting any increases over the first years of appointment is intended to reflect and align with shareholder views in the engagement process that market alignment should be achieved in 2-3 years following appointment.

 

Discussions with shareholders were not limited to the response to the vote. We have also started discussions with shareholders on the renewal of our Remuneration Policy in 2024 and its implementation. The feedback received to date has been valuable and will help to shape our final proposals. We will engage further with shareholders on the Remuneration Policy as required ahead of the Committee finalising the proposed approach which will be published in the remuneration report early next year.

 

We would like to thank all the shareholders who spent time spent engaging with us. The perspectives of our major shareholders are a critical input into the Committee's deliberations, and we continue to be committed to ongoing and open dialogue, including as we consider our 2024 Remuneration Policy.

 

Unilever PLC is publishing this statement as required by the UK Corporate Governance Code in response to the votes received against the DRR resolution at our AGM on 3 May 2023.

 

Andrea Jung

Chair of the Compensation Committee

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRNKKBNABDDBKN
Date   Source Headline
23rd May 20228:55 amRNSTransaction in Own Shares
19th May 20226:17 pmRNSTransaction in Own Shares
18th May 20225:59 pmRNSTransaction in Own Shares
17th May 20225:38 pmRNSTransaction in Own Shares
16th May 20225:45 pmRNSTransaction in Own Shares
12th May 20225:57 pmRNSTransaction in Own Shares
11th May 20221:09 pmRNSDirector/PDMR Shareholding
9th May 20225:24 pmRNSTransaction in Own Shares
6th May 20225:29 pmRNSTransaction in Own Shares
5th May 20225:30 pmRNSTransaction in Own Shares
4th May 20226:29 pmRNSBoard Committee Membership
4th May 20226:15 pmRNSResult of AGM
3rd May 20228:29 amRNSTotal Voting Rights
28th Apr 20225:53 pmRNSTransaction in Own Shares
28th Apr 20227:00 amRNS1st Quarter 2022 Trading Statement
27th Apr 20225:32 pmRNSTransaction in Own Shares
25th Apr 20225:34 pmRNSTransaction in Own Shares
20th Apr 20225:29 pmRNSTransaction in Own Shares
19th Apr 20225:34 pmRNSTransaction in Own Shares
14th Apr 20225:46 pmRNSTransaction in Own Shares
13th Apr 20225:39 pmRNSTransaction in Own Shares
13th Apr 202212:01 pmRNSDirector/PDMR Shareholding
12th Apr 20225:29 pmRNSTransaction in Own Shares
11th Apr 20225:34 pmRNSTransaction in Own Shares
8th Apr 20225:18 pmRNSTransaction in Own Shares
7th Apr 20225:35 pmRNSTransaction in Own Shares
7th Apr 202211:40 amRNSPost Stabilisation Notice - Unilever, GBP, 6y
6th Apr 20225:24 pmRNSTransaction in Own Shares
5th Apr 20225:23 pmRNSTransaction in Own Shares
4th Apr 20225:32 pmRNSTransaction in Own Shares
4th Apr 20223:06 pmRNSTotal Voting Rights
1st Apr 20225:39 pmRNSTransaction in Own Shares
31st Mar 20225:31 pmRNSTransaction in Own Shares
30th Mar 20225:38 pmRNSTransaction in Own Shares
30th Mar 20222:14 pmRNSDirector/PDMR Shareholding
29th Mar 20225:39 pmRNSTransaction in Own Shares
29th Mar 20221:14 pmRNSDirector/PDMR Shareholding
28th Mar 20225:25 pmRNSTransaction in Own Shares
25th Mar 20226:10 pmRNSDirector/PDMR Shareholding
25th Mar 20225:19 pmRNSTransaction in Own Shares
25th Mar 20223:27 pmRNSDirector/PDMR Shareholding
24th Mar 20226:08 pmRNSTransaction in Own Shares
23rd Mar 20226:24 pmRNSTransaction in Own Shares
23rd Mar 20228:00 amRNSCommencement of Share Buy-Back Programme
22nd Mar 20224:30 pmRNSNotice of AGM
21st Mar 20225:54 pmRNSDirector/PDMR Shareholding - Replacement
15th Mar 202212:33 pmRNSDirector/PDMR Shareholding
11th Mar 20224:00 pmRNSAGM Director elections and re-elections
9th Mar 20225:13 pmRNSDirector/PDMR Shareholding
9th Mar 20225:05 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.